Historic FDA approval marks first nonopioid breakthrough since Clinton era
The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...
FDA approves new painkiller designed to avoid opioid addiction risk
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
Psychology Today22h
Opioid Crisis: Grading the Progress of National Initiatives
Drug experts Drs. Volkow and McLellan set out a road map to reverse the opioid epidemic in 2016. Find out how we're doing now ...
Hosted on MSN13d
Junk food under the gun as forces in Washington align to Make America Healthy Again
The intensifying focus in Washington has triggered a new level of interest on ... Food companies have tapped into “the same ...
Justice Department sues Walgreens over alleged unlawful opioid prescriptions
The Justice Department filed a lawsuit against Walgreens accusing the drugstore giant of filling millions of illegitimate ...
FDA approves Vertex's non-opioid painkiller, first new kind of pain medicine in decades
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
STAT3d
RFK Jr.’s views on addiction win a surprising endorsement: his cousin Patrick
Patrick Kennedy suggests Robert F. Kennedy Jr. would be open to use of addiction medications as well as "wellness farms" for ...
Kitsap Sun10d
Kitsap paramedics will provide emerging medication to aid opioid recovery
The Washington state Department of Health launched ... Washingtonians live healthy and fulfilling lives, and to stop this opioid crisis from robbing those lives from our neighbors, friends ...
FDA approves new type of nonopioid painkiller for acute pain
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
Purdue Pharma, Sackler family agree to $7 billion settlement over opioid crisis
The settlement, in principle, would not shield Purdue Pharma or the Sackler family from additional liability over their role in the opioid crisis.